Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2011; 17(32): 3709-3715
Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3709
Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3709
Figure 1 Distribution of patients according to transfusion status during periods A and B.
The proportion of patients who received HT was significantly lower in period B than period A (aP < 0.0001). AT: Autologous transfusion; HT: Homologous transfusion.
- Citation: Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol 2011; 17(32): 3709-3715
- URL: https://www.wjgnet.com/1007-9327/full/v17/i32/3709.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i32.3709